Results 161 to 170 of about 279,219 (179)

Candidaemia in Haematological Malignancy Patients From a SEIFEM Study: Epidemiological Patterns According to Antifungal Prophylaxis [PDF]

open access: yesMycoses, 2020
Candidaemia is an important infectious complication for haematological malignancy patients.
Alessandro Busca   +2 more
exaly   +3 more sources

Consensus Guidelines for Antifungal Prophylaxis in Haematological Malignancy and Haemopoietic Stem Cell Transplantation, 2021

open access: yesInternal Medicine Journal, 2021
Antifungal prophylaxis can reduce morbidity and mortality from invasive fungal disease (IFD). However, its use needs to be optimised and appropriately targeted to patients at highest risk to derive the most benefit.
Jason Roberts   +2 more
exaly   +2 more sources

The Role of Primary Antifungal Prophylaxis in Patients With Haematological Malignancies

open access: yesClinical Microbiology and Infection, 2014
Invasive fungal Infections (IFIs) represent important complications in patients with haematological malignancies. Chemoprevention of IFIs may play an important role in this setting, but in the past decades the majority of antifungal drugs utilized ...
Livio Pagano, M Caira
exaly   +2 more sources

Outcomes of Antifungal Prophylaxis in High-Risk Liver Transplant Recipients [PDF]

open access: yesTransplant Infectious Disease, 2009
Antifungal prophylaxis for liver transplant recipients (LTRs) is common among patients considered at high risk of infection, but optimal prophylaxis duration and drug has not been defined.
R M Merion, P G Pappas, S Hadley
exaly   +2 more sources

The Impact of Antifungal Prophylaxis in Lung Transplant Recipients.

Annals of the American Thoracic Society, 2021
Raymund R Razonable   +2 more
exaly  

Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections

Pharmaceutics, 2022
Sandrine Marchand   +2 more
exaly  

Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients

American Journal of Transplantation, 2015
Gregory Eschenauer, C J Clancy, E J Kwak
exaly  

Antifungal Prophylaxis for Severely Neutropenic Chemotherapy Recipients

Cancer, 2002
Coleman Rotstein   +2 more
exaly  

Antifungal Prophylaxis in Lung Transplant: A Survey of United States' Transplant Centers

Clinical Transplantation, 2019
Raymund R Razonable   +2 more
exaly  

Home - About - Disclaimer - Privacy